Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02777502 · ClinicalTrials.gov registry record

Effects of Cannabidiol on Marijuana-seeking in Humans

A clinical trial of Marijuana Abuse, sponsored by Wayne State University.

Completed
Registry status
30
Enrollment target
1
Study location

NCT02777502: Completed study of Marijuana Abuse, sponsored by Wayne State University.

NCT02777502 is a study of Marijuana Abuse that has completed, run by Wayne State University. The registered enrollment target is 30 participants, below the 91-participant average among 4 other Marijuana Abuse trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02777502, a study of Marijuana Abuse, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of the proposed study is to investigate the effectiveness of cannabidiol for reducing marijuana seeking in non-treatment seeking volunteers. Cannabidiol is a cannabinoid (similar to cannabis, or marijuana) present in marijuana that alters some of the effects of marijuana. Assess the ability of acute smoked CBD pretreatment to reduce marijuana-seeking behavior and increase price-elasticity of marijuana demand.

Conditions Studied

Marijuana Abuse

Study Locations (1)

Michigan

  • Tolan Park Medical Building - Detroit

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-01-01
Est. Completion 2019-01-31
Wayne State University

163 total trials

What the finished NCT02777502 record still lists

NCT02777502 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 91-participant average among 4 other Marijuana Abuse trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Marijuana Abuse appearing as the primary indexed condition, and to 0 interventions.

NCT02777502 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02777502 about?

NCT02777502 is a clinical study titled "Effects of Cannabidiol on Marijuana-seeking in Humans". The purpose of the proposed study is to investigate the effectiveness of cannabidiol for reducing marijuana seeking in non-treatment seeking volunteers. Cannabidiol is a cannabinoid (similar to cannabis, or marijuana) present in marijuana that alters some of the effects of marijuana. Assess the abi...

What is the current status of trial NCT02777502?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-01-01. Estimated completion is 2019-01-31.

What conditions does trial NCT02777502 study?

This clinical trial studies the following conditions: Marijuana Abuse.

Who is sponsoring clinical trial NCT02777502?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02777502 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Marijuana Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02777502, the US trial registry maintained by the National Library of Medicine. NCT02777502 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.